A new ML-guided platform can design thousands of new enzymes, predict how they will behave in the real world, and test their performance.

The partners will adapt Eukarÿs' C3P3 engineered enzyme tech to work with adeno-associated virus vectors to boost biomanufacturing yields.

The investment license allows Kraig Biocraft Labs to scale production significantly and begin addressing requests for materials and quote.

Researchers say study represents a resource that could also help to dissect Y-gene functions in other tissues.

BioChatter can be adapted to specific research areas to pull data from biomedical databases and literature. Further, ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...